Meeting
2019 ASCO Annual Meeting
Clonal evolution and osimertinib resistance mechanisms identified by whole exome and transcriptome sequencing in EGFR mutant NSCLC.
Authors
Nitin Roper
Thoracic and GI Malignancies Branch, CCR, NCI, NIH, Bethesda, MD
Nitin Roper , Anna-Leigh Brown , Sivasish Sindiri , Constance M. Cultraro , Shaojian Gao , Chul Kim , Chuong D. Hoang , Tapan K Maity , Elizabeth Akoth , Arun Rajan , Abhilash Karavattu Venugopalan , Christopher Trindade , Jun S. Wei , Anna Panchenko , Stephen M. Hewitt , Javed Khan , Udayan Guha
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Clinical Trial Registration Number
NCT02759835
Citation
J Clin Oncol 37, 2019 (suppl; abstr 9049)
DOI
10.1200/JCO.2019.37.15_suppl.9049
Abstract #
9049
Poster Bd #
372
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
A nation-wide genomic screening project for further development of targeted therapies in treatment-refractory non–small-cell lung cancer (LC-SCRUM-TRY).
First Author: Hiroki Izumi
Poster
2017 ASCO Annual Meeting
Investigating novel resistance mechanisms to third generation EGFR TKI osimertinib in non-small cell lung cancer patients using next generation sequencing.
First Author: Qiuxiang Ou
Poster
2023 ASCO Annual Meeting
Elucidating the genomic and transcriptomic landscape of L858R vs ex19del EGFR-mutated NSCLC.
First Author: Stephanie Pei Li Saw
Poster
2023 ASCO Annual Meeting
Association of alterations in multiple tumor suppressor genes with poor outcomes in patients with EGFR-mutant lung cancer.
First Author: Paul Stockhammer